Copyright © 2021 InvestorPlace Media, LLC All rights reserved 1125 N Charles St, Baltimore, MD 21201

Ocugen (NASDAQ: OCGN) was up more than 60% on Friday after announcing on Tuesday that it would partner with Bharat Biotech to bring its Covid-19 vaccine to US Markets

COVAXIN is a notable newbie to the vaccine talk as Bharat Biotech believes their vaccine can be effective against the UK as well Variant of Covid-19 according to last month’s Phase II clinical trial results.This vaccine can also be stored at room temperature compared to the ultra-cold freezers required for mRNA vaccines already on the market

The deal was originally announced in late December, but the details weren’t revealed until this week, Ocugen will have US Rights to the vaccine and responsible for developing, regulating and commercializing it in that market In return for these services, OCGN retains 45% of U’s profitsS. Markets

Ocugen had a volatile week with OCGN stock falling after the company released details of the executive agreement on Tuesday

At the time of publication, Vivian Medithi held (neither directly nor indirectly) positions in the securities referred to in this article

Financial market data from FinancialContent Services, Inc All rights reserved by Nasdaq
Citations were delayed by at least 15 minutes, all others by at least 20 minutes
Copyright ©
2021 InvestorPlace Media, LLC All rights reserved 1125 N Charles St, Baltimore, MD 21201

OCGN-Share

World News – CA – OCGN-Share: What you should know today as Ocugen Soars

Source: https://investorplace.com/2021/02/ocgn-stock-what-to-know-as-ocugen-soars-today/